Placental Tissue 2.0TM
Americord is the pioneer of and only cord blood bank to offer Placental Tissue 2.0TM – because stem cell banking should benefit the whole family.
We know your first priority is the well-being of your child, but with Placental Tissue 2.0TM Americord is also committed to helping the rest of your family live healthier, longer lives. These stem cells can be used to treat your newborn, but also every other first- or- second-degree relative. That means mom, dad, siblings, and even grandma and grandpa can use these cells, should the need ever arise. Banking this tissue is an opportunity to give your entire family access to the future of regenerative stem cell medicine.
Through our patented process, Americord can collect two types of valuable stem cells from the placenta at birth: mesenchymal stem cells (MSCs), and an entirely unique and new kind of stem cell called amniotic epithelial cells (or AECs). The MSCs collected in this process are more densely-packed and, when paired with the AECs, provide a more efficient resource that opens up many new treatment opportunities.
This stem cell source is currently used to treat:
- Eye conditions that can lead to blindness
- Diabetic ulcers, which are prone to infections and can lead to amputations
- Surgical wounds, to promote faster, healthier healing
There are also advanced clinical trials for dozens of conditions that do not yet have established treatments using stem cells from cord blood or tissue, but are showing promise with treatment from Placental Tissue 2.0TM stem cells. These include:
- Cerebral palsy
- Prostate cancer
- Throat cancer
- Neurological dysfunction
- Kidney failure
- Heart conditions
- Injuries to the joints and spine
Placental tissue banking is the process of collecting stem cells from the placenta after delivery and storing them for future medical or therapeutic use.
The placenta is a valuable source of two types of stem cells, mesenchymal stem cells (MSCs) and amniotic epithelial cells (AECs), that can already be used to treat wounds and certain eye conditions, and are also at the center of advanced clinical trials to establish new treatments for a wide range of conditions, including cerebral palsy, cancers, organ failure, and injuries to bones and joints.
Those wishing to bank placental tissue can obtain a collection kit from Americord. After delivery, the placenta is placed in the kit and collected by a medical courier, who takes it to the lab for processing and storage.
The stem cells in placental tissue can be safely used for all first- and- second-degree relatives, a revolutionary development in stem cell medicine. This fact, combined with the incredibly diverse set of treatment possibilities in the clinical trial phase, make placental tissue banking an important consideration for any family.
Placental tissue is currently approved to treat wounds, including surgical scars, and certain eye conditions, including some that can lead to blindness. The treatment potential being explored is even wider, as a number of cancers, organ conditions, and injuries to bones and joints are the subject of trials.
Like cord blood, placental tissue can be safely and effectively stored indefinitely in proper conditions. Americord’s most common storage plans are for 20 years. These plans can be extended at any time, and lifetime storage plans are also available.
Private placental tissue banking became widespread in 2011, the same year Americord began offering the service. Americord debuted Placental Tissue 2.0™ in 2019, the most advanced process that enables the broadest application of stem cells.
Americord has flexible payment options to make stem cell banking as affordable as possible for more families, including one-time, annual, and monthly payment plans. First-year costs can be as low as $1,549.
The stem cells in placental tissue can safely be used for all first- and- second-degree family members. That means that banking provides siblings, parents, and even grandparents with access to treatments and trials using these stem cells.